Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373103 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
A pharmacophore mapping approach, derived from previous experience of PIKK family enzymes, was used to identify a hit series of selective inhibitors of the mammalian target of rapamycin (mTOR). Subsequent refinement of the SAR around this hit series based on a tri-substituted triazine scaffold has led to the discovery of potent and selective inhibitors of mTOR.
Graphical abstractThe discovery and optimisation of a novel series of inhibitors of mTOR kinase are described. Compound 15 has low nanomolar potency against mTOR kinase and is highly selective relative to PI3Kα.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Keith A. Menear, Sylvie Gomez, Karine Malagu, Christine Bailey, Kristel Blackburn, Xiao-Ling Cockcroft, Sally Ewen, Alexandra Fundo, Armelle Le Gall, Gesine Hermann, Luisa Sebastian, Mihiro Sunose, Thomas Presnot, Eleanor Torode, Ian Hickson,